Third Wave Analytics

Third Wave Analytics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Third Wave Analytics is a private, revenue-generating software company that has developed Lockbox LIMS, a highly-rated, cloud-native laboratory information management platform. The company targets biotech, NGS, core, and QC labs, offering a configurable solution that scales from research to commercial operations while ensuring compliance with CAP/CLIA, HIPAA, and 21 CFR Part 11. Its business model is based on selling software subscriptions and related professional services, leveraging the Salesforce ecosystem for deployment and scalability. The company appears to be in a growth phase, as evidenced by strong customer testimonials, high ratings on platforms like G2 and Capterra, and an active schedule of educational webinars.

AI / Machine LearningDigital Health

Technology Platform

Lockbox LIMS: A cloud-native, configurable Laboratory Information Management System (LIMS) built natively on the Salesforce platform and hosted on AWS. It features a modular architecture for sample tracking, storage management, protocol execution, and inventory management, with point-and-click customization and built-in compliance (21 CFR Part 11, HIPAA, CLIA, CAP).

Opportunities

The growing demand for cloud-based, configurable LIMS solutions from biotechs and labs scaling from R&D to clinical/commercial stages presents a significant expansion opportunity.
Leveraging the Salesforce ecosystem allows for seamless integration with business operations, creating a sticky enterprise solution.
Further integration of AI/ML for predictive analytics and workflow optimization can differentiate the platform and create upselling opportunities.

Risk Factors

Intense competition from established LIMS vendors and new SaaS entrants could pressure pricing and market share.
Heavy dependence on the Salesforce platform creates vendor lock-in and strategic risk if Salesforce changes its model or pricing.
A downturn in biotech funding could reduce capital expenditure on new lab software, impacting sales cycles and growth.

Competitive Landscape

Third Wave competes in a fragmented LIMS market against large, established vendors like LabVantage, LabWare, and Thermo Fisher, as well as other cloud-native players such as Benchling (which started in ELN). Its key differentiator is being a native Salesforce application, offering deep configurability and ease of integration for labs already in the Salesforce ecosystem. Competition is based on functionality, user experience, implementation speed, cost, and compliance capabilities.